SHSE:603566 (China)
Â
Class A
Â¥
10.39
+0.11 (+1.07%)
Jul 31
Business Description
Pulike Biological Engineering Inc
ISIN : CNE1000025N0
Share Class Description:
SHSE:603566: Class ATotal Employee Number:
1,519Compare
Compare
Traded in other countries / regions
603566.China Index Membership
SSE Composite Index IPO Date
2015-05-18Description
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 27.69 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.14 | |||||
Interest Coverage | 340.53 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.99 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.8 | |||||
3-Year EBITDA Growth Rate | 7 | |||||
3-Year EPS without NRI Growth Rate | -9.1 | |||||
3-Year Book Growth Rate | -1.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.29 | |||||
9-Day RSI | 54.28 | |||||
14-Day RSI | 51.34 | |||||
3-1 Month Momentum % | -18.21 | |||||
6-1 Month Momentum % | -29.47 | |||||
12-1 Month Momentum % | -33.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.82 | |||||
Quick Ratio | 3.19 | |||||
Cash Ratio | 2.05 | |||||
Days Inventory | 167.01 | |||||
Days Sales Outstanding | 122.02 | |||||
Days Payable | 101.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.77 | |||||
Dividend Payout Ratio | 1.26 | |||||
3-Year Dividend Growth Rate | 44.2 | |||||
Forward Dividend Yield % | 5.77 | |||||
5-Year Yield-on-Cost % | 13.76 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 5.66 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.74 | |||||
Operating Margin % | 16.34 | |||||
Net Margin % | 16.3 | |||||
EBITDA Margin % | 17.95 | |||||
FCF Margin % | 18.89 | |||||
OCF Margin % | 25.74 | |||||
ROE % | 6.59 | |||||
ROA % | 5.51 | |||||
ROIC % | 7.56 | |||||
3-Year ROIIC % | -14.77 | |||||
ROC (Joel Greenblatt) % | 14.13 | |||||
ROCE % | 6.96 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.78 | |||||
Forward PE Ratio | 16.36 | |||||
PE Ratio without NRI | 21.87 | |||||
Shiller PE Ratio | 19.6 | |||||
PS Ratio | 3.4 | |||||
PB Ratio | 1.36 | |||||
Price-to-Tangible-Book | 1.55 | |||||
Price-to-Free-Cash-Flow | 18.16 | |||||
Price-to-Operating-Cash-Flow | 13.27 | |||||
EV-to-EBIT | 15.63 | |||||
EV-to-EBITDA | 15.63 | |||||
EV-to-Revenue | 2.8 | |||||
EV-to-FCF | 14.84 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Projected-FCF | 1.45 | |||||
Price-to-Median-PS-Value | 0.45 | |||||
Price-to-Graham-Number | 1.23 | |||||
| Price-to-Net-Current-Asset-Value | 4.29 | |||||
| Price-to-Net-Cash | 19.6 | |||||
Earnings Yield (Greenblatt) % | 6.4 | |||||
FCF Yield % | 5.57 | |||||
Forward Rate of Return (Yacktman) % | -14.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulike Biological Engineering Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,060.498 | ||
| EPS (TTM) (Â¥) | 0.5 | ||
| Beta | 1.2439 | ||
| 3-Year Sharpe Ratio | -0.86 | ||
| 3-Year Sortino Ratio | -0.98 | ||
| Volatility % | 25.19 | ||
| 14-Day RSI | 51.34 | ||
| 14-Day ATR (Â¥) | 0.311897 | ||
| 20-Day SMA (Â¥) | 10.334 | ||
| 12-1 Month Momentum % | -33.9 | ||
| 52-Week Range (Â¥) | 9.56 - 15.79 | ||
| Shares Outstanding (Mil) | 346.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulike Biological Engineering Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulike Biological Engineering Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.400000 Cash Dividend | 2026-06-16 | 10.55 (+0.86%) | ||
| CNY 0.200000 Cash Dividend | 2025-10-17 | 14.21 (-0.14%) | ||
| CNY 0.400000 Cash Dividend | 2025-06-11 | 15.12 (+2.09%) | ||
| 2:1 Stock Split | 2016-05-31 | 22.08 (-0.47%) |
Show
Entries
Pulike Biological Engineering Inc Frequently Asked Questions
What is Pulike Biological Engineering Inc(SHSE:603566)'s stock price today?
The current price of SHSE:603566 is ¥10.39. The 52 week high of SHSE:603566 is ¥15.79 and 52 week low is ¥9.56.
When is next earnings date of Pulike Biological Engineering Inc(SHSE:603566)?
The next earnings date of Pulike Biological Engineering Inc(SHSE:603566) is .
Does Pulike Biological Engineering Inc(SHSE:603566) pay dividends? If so, how much?
The Dividend Yield %  of Pulike Biological Engineering Inc(SHSE:603566) is 5.77% (As of Today), Highest Dividend Payout Ratio of Pulike Biological Engineering Inc(SHSE:603566) was 1.74. The lowest was 0.34. And the median was 0.9. The  Forward Dividend Yield % of Pulike Biological Engineering Inc(SHSE:603566) is 5.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pulike Biological Engineering Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers